Beijing CytoNiche Biotechnology
PrivateLast Round
Series B
Extension
Sep 15, 2025
Total Funding Raised
$47M
Company Overview
Beijing CytoNiche Biotechnology is a biotechnology company that provides integrated 3D cell manufacturing platforms and solutions for the cell and gene therapy industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing CytoNiche Biotechnology Comparables
Compare Beijing CytoNiche Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Lepure Biotech Co., Ltd. | 76% | |
| Sartorius Aktiengesellschaft | 74% | |
| Danaher Corporation | 73% | |
Beijing CytoNiche Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 15, 2025 | ||||
| Series B | Mar 3, 2022 | ||||
| Series A Extension | Apr 28, 2021 | ||||
| Series A | Sep 2, 2020 | ||||
| Pre Seed | Aug 22, 2019 |
Beijing CytoNiche Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bencao Capital | Series B, Series A Extension |
| 德同资本 | Series B, Series A |
| Changjiang Growth Capital | Pre Seed |
| CICC Capital | Series B Extension |
| 北京市新材料产业投资基金 | Series B Extension |
| ICBC Financial Asset Investment | Series B Extension |
| Yijing Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
Grew 60% QoQ from 5 to 8 employees.
- Sep 2, 2020
Raised Series A round with investment from 德同资本.
Beijing CytoNiche Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beijing CytoNiche Biotechnology's valuation, stock price, and market status.